Clinical trial
End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric…
NCT00374582 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00374582 |
|---|---|
| Title | End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA) |
| Official title | End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA) |
| Lead sponsor | University of Cincinnati, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | End Stage Liver Disease |
| Intervention type | Device |
| Interventions | Bodystat Quadscan 4000, bodystat quadscan 400 |
| Enrollment | 30 |
| Start date | Sep 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 11, 2006 |
| Last update posted | Mar 4, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: